Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
- PMID: 25435897
- PMCID: PMC4247563
- DOI: 10.1186/s12991-014-0035-x
Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
Abstract
Background: The relationship between substance use disorders and psychiatric pathology is still an open question. The main aim of the present study was to verify whether the five psychopathological dimensions identified through the SCL-90 tool in a previous study carried out on patients with heroin addiction entering an outpatient opioid agonist treatment (OAT) were also observable in those entering a residential treatment community (TC). Further aims were to look at differences in the psychopathological profiles of patients entering a TC versus an OAT treatment and at the correlation between gender and the observed psychopathology.
Methods: A confirmatory factor analysis was performed on the results of SCL-90 filled by 1,195 patients with heroin dependence entering TC treatment. It replicates the extraction method previously used on 1,055 OAT patients with heroin addiction by using a principal component factor analysis (PCA). The association between the kind of treatment received (TC or OAT), gender, and the psychopathological dimensions was assessed through logistic regression and general linear model (GLM) analysis.
Results: The PCA carried out on the SCL-90 results of patients entering a TC yielded a five-factor solution, confirming the same dimensions observed in patients entering an OAT: 'worthlessness and being trapped', 'somatization', 'sensitivity-psychoticism', 'panic anxiety', and 'violence-suicide'. The logistic regression analysis showed a statistically significant association between 'somatization' and 'violence-suicide' severity score and OAT. GLM analysis showed that psychopathological factorial scores for 'worthlessness-being trapped', 'somatic symptoms', and 'panic anxiety' dimensions were more severe in OAT vs TC male patients and in TC vs OAT female ones. 'Violence suicide' followed the same severity pattern for males, but did not differ in TC vs OAT females, while 'sensitivity-psychoticism' did not differ in OAT vs TC patients. The five dimensions did not differ in OAT males vs females.
Conclusions: Our research appears to confirm the existence of a specific aggregation of psychological/psychiatric features within the category of individuals with heroin addiction. It also shows a correlation between the dominant psychopathological subgroup and the assignment to TC versus OAT. Further research is needed to clarify the differences between the five psychopathological subgroups and their determinants.
Keywords: Gender differences; Opioid agonist treatment; Psychopathological symptoms; Residential treatment community; SCL-90.
Similar articles
-
Toward the Identification of a Specific Psychopathology of Substance Use Disorders.Front Psychiatry. 2017 Apr 27;8:68. doi: 10.3389/fpsyt.2017.00068. eCollection 2017. Front Psychiatry. 2017. PMID: 28496418 Free PMC article. Review.
-
The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment.Ann Gen Psychiatry. 2016 Nov 8;15:29. doi: 10.1186/s12991-016-0119-x. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 27833645 Free PMC article.
-
Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?Ann Gen Psychiatry. 2016 Apr 26;15:13. doi: 10.1186/s12991-016-0100-8. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 27118983 Free PMC article.
-
Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?Ann Gen Psychiatry. 2011 May 15;10:17. doi: 10.1186/1744-859X-10-17. Ann Gen Psychiatry. 2011. PMID: 21569624 Free PMC article.
-
Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine.Ann N Y Acad Sci. 2000;909:186-216. doi: 10.1111/j.1749-6632.2000.tb06683.x. Ann N Y Acad Sci. 2000. PMID: 10911931 Review.
Cited by
-
A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.Int J Ment Health Addict. 2017 Aug;15(4):812-825. doi: 10.1007/s11469-017-9752-0. Epub 2017 Apr 3. Int J Ment Health Addict. 2017. PMID: 29051714 Free PMC article.
-
Toward the Identification of a Specific Psychopathology of Substance Use Disorders.Front Psychiatry. 2017 Apr 27;8:68. doi: 10.3389/fpsyt.2017.00068. eCollection 2017. Front Psychiatry. 2017. PMID: 28496418 Free PMC article. Review.
-
Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients.Neuropsychiatr Dis Treat. 2019 Dec 18;15:3453-3459. doi: 10.2147/NDT.S222567. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31908460 Free PMC article.
-
Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later.J Clin Med. 2020 Jun 18;9(6):1913. doi: 10.3390/jcm9061913. J Clin Med. 2020. PMID: 32570932 Free PMC article.
-
Comorbid Psychopathology and Alcohol Use Patterns among Methadone Maintenance Treatment Patients.J Addict. 2015;2015:197652. doi: 10.1155/2015/197652. Epub 2015 Mar 23. J Addict. 2015. PMID: 25878919 Free PMC article.
References
-
- A.P.A . Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5. Washington, D.C: American Psychiatric Association; 2013.
-
- Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19. doi: 10.1001/archpsyc.1994.03950010008002. - DOI - PubMed
-
- Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–816. doi: 10.1001/archpsyc.61.8.807. - DOI - PubMed
-
- Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ. Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact? J Stud Alcohol. 2000;61:101–110. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous